drugset / Trial / NCT02652650

A Study to Investigate the Effect of JNJ-63623872 at Steady-state on the Steady-state Pharmacokinetics of Ethinylestradiol and Norethindrone

NCT02652650

Phase 1 Completed 18 enrolled Janssen Research & Development, LLC
NaSingle-groupOpen-label

Summary

The purpose of this study is to evaluate the effect of steady-state concentrations of JNJ-63623872 on the steady-state pharmacokinetics of ethinylestradiol and norethindrone in healthy female participants.

Timeline

Start
2015-12
Primary completion
2016-06
Completion
2016-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Norethindrone Unknown 1 mg Oral
Subject Pimodivir Small molecule 600 mg
Subject ethinyl estradiol Small molecule 35 ug Oral

Indications

No indication recorded.